Zhichen Sun

发表

Hepatitis B Virus Induces a Novel Inflammation Network Involving Three Inflammatory Factors, IL-29, IL-8, and Cyclooxygenase-2

Jianguo Wu, Ying Zhu, Yi Yu, 2011, The Journal of Immunology.

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.

Jia Wei, Baorui Liu, Zhichen Sun, 2019, The Journal of clinical investigation.

Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity

Zhichen Sun, yang-xin fu, J. Qiao, 2022, The Journal of clinical investigation.

Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells

Zhichen Sun, yang-xin fu, Longchao Liu, 2021, Nature Biomedical Engineering.

Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

Jia Wei, Baorui Liu, Zhichen Sun, 2020, Cancer management and research.

Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action

Jianguo Wu, Ying Zhu, Zhichen Sun, 2017, Scientific Reports.

Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice

Zheng Zhang, Fu-Sheng Wang, Zhichen Sun, 2017, Hepatology.

Cyclooxygenase-2Inflammatory Factors, IL-29, IL-8, and Inflammation Network Involving Three Hepatitis B Virus Induces a Novel

Jianguo Wu, Ying Zhu, Y. Mu, 2011 .

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Zhichen Sun, Haidong Dong, yang-xin fu, 2018, Nature Communications.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Scientific Reports.

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Journal of Virology.

IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer

Zhichen Sun, yang-xin fu, Jiankun Zhu, 2022, Nature Cell Biology.

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors

Jia Wei, Baorui Liu, Zhichen Sun, 2022, Journal of Hematology & Oncology.

Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action

Jianguo Wu, Ying Zhu, Zhichen Sun, 2017, Scientific Reports.

Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination

Zhichen Sun, L. Su, yang-xin fu, 2016, The Journal of Immunology.

MHC class II restricted neoantigen: A promising target in tumor immunotherapy.

Baorui Liu, Jia Wei, Zhichen Sun, 2017, Cancer letters.

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Zhichen Sun, yang-xin fu, B. Sumer, 2021, Nature Communications.

Targeting tumor cells with antibodies enhances anti-tumor immunity

Zhichen Sun, Zhichen Sun, yang-xin fu, 2018, Biophysics reports.

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control

Zhichen Sun, yang-xin fu, Jiyun Shi, 2019, Nature Communications.

Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cells.

Zhichen Sun, Hua Peng, Hong Tang, 2020, JCI insight.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Scientific Reports.

Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells

Baorui Liu, Lifeng Wang, Lixia Yu, 2020, International journal of nanomedicine.

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

Zhichen Sun, yang-xin fu, Kaiting Yang, 2017, Cancer Immunology Research.

Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors

Lin Li, Baorui Liu, X. Qian, 2023, Advanced science.

CTLA-4 Limits Anti-CD20–Mediated Tumor Regression

Zhichen Sun, yang-xin fu, Zhenhua Ren, 2016, Clinical Cancer Research.

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Zhichen Sun, Haidong Dong, yang-xin fu, 2018, Nature Communications.

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy

Zhichen Sun, yang-xin fu, Zhida Liu, 2020, Nature Communications.

Implication of 99mTc-sum IL-2 SPECT/CT in immunotherapy by imaging of tumor-infiltrating T cells

Xiaotu Ma, Fan Wang, Zhichen Sun, 2023, Journal for ImmunoTherapy of Cancer.

CT in immunotherapy by imaging of tumor-infiltratingTcells

Xiaotu Ma, Fan Wang, Zhichen Sun, 2023 .

Feasible and efficient identification of neoantigens for personalized cancer immunotherapy in advanced refractory epithelial cancer patients.

Jia Wei, Baorui Liu, Zhichen Sun, 2017 .

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.

Jia Wei, Baorui Liu, Zhichen Sun, 2019, The Journal of clinical investigation.

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating 1 lymphocytes for potent antitumor therapy

Zhichen Sun, Zhida Liu, J. Bae, 2020 .

Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

Zhichen Sun, Kangxin Wang, Qin Liu, 2020 .

Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

Yiwen Xu, Jia Wei, Baorui Liu, 2020 .

Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor

Baorui Liu, Zhichen Sun, F. Meng, 2023, Bioengineering & translational medicine.

STING licensing of type I dendritic cells potentiates antitumor immunity

Nan Yan, Zhichen Sun, B. Sumer, 2024, Science Immunology.